Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Key Record Dates Identifier: NCT02141282
Brief Title: A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia (CLL) Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor Therapy

First Submitted : May 12, 2014
First Submitted that Met QC Criteria : May 15, 2014
First Posted : May 19, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : November 20, 2019
Last Update Posted : November 21, 2019